For more than a decade, a 44-year-old professional in Mumbai lived with a silent but relentless enemy—uncontrolled high blood pressure. Despite taking multiple medications, his blood pressure remained stubbornly high at 170/110 mmHg, accompanied by severe headaches and dizzy spells. At Wockhardt Hospitals, Mumbai Central, a team led by Dr Prashant Makhija (Consultant Neurologist), Dr Pranav Ghody (Consultant Endocrinologist) and Dr Dharav Kheradia (Consultant Neuro & Vascular Interventional Radiologist) decided to look beyond the obvious. What they uncovered not only spared the patient from unnecessary surgery but also highlighted how precision diagnostics are transforming the delivery of healthcare.

The decade-long high blood pressure

When a young patient’s blood pressure resists standard treatment, physicians suspect a hidden trigger. Dr Makhija first investigated whether obstructive sleep apnea might be the culprit. The sleep study confirmed it, yet the severity of the hypertension suggested something more complex. Dr Ghody then led a detailed hormonal evaluation, which revealed borderline low potassium and biochemical signs of primary aldosteronism—a rare disorder in which the adrenal glands produce too much aldosterone, driving blood pressure up.

An MRI showed a small nodule on the patient’s right adrenal gland, but the presence of a nodule doesn’t always mean surgery will help. To be certain, Dr Dharav Kheradia performed adrenal vein sampling, a technically demanding procedure that measures hormone levels directly from each adrenal gland. The results were decisive: both glands were overproducing aldosterone. Surgery to remove a single gland would have been futile. Instead, the team tailored a medical treatment plan, combined with therapy for his sleep apnea, that finally brought his blood pressure under control—without the risks and recovery of an unnecessary operation.

This is more than a single patient’s success story. It illustrates how modern healthcare is evolving from a “treat what you see” approach to a “treat what you know” philosophy—one powered by precision diagnostics and multidisciplinary collaboration. A successful case that shows how precision diagnostics in rare hormonal high blood pressure. A similar story we had covered earlier was on Medicover and how they treated a double Renal Transplant.

Global Case Studies – Milan and Tehran

Across the world, similar breakthroughs are changing lives. In Italy, a 65-year-old woman on six different blood pressure medications was found to have primary aldosteronism. But unlike the Mumbai case, her adrenal vein sampling pinpointed the excess hormone production to a single adrenal gland. Surgeons removed it laparoscopically, and her blood pressure improved dramatically, allowing her to reduce her medications significantly. Here, the same diagnostic tool guided doctors toward surgery rather than away from it—underscoring that the value of advanced testing lies in clarity, not in a predetermined outcome.

Another striking example comes from Iran, where a patient with severe, resistant hypertension was eventually diagnosed with a rare combination of pheochromocytoma and hyperaldosteronism. The careful hormonal work-up revealed the dual endocrine drivers, and surgical removal of the affected adrenal tissue normalised both hormone levels and blood pressure. Without such an in-depth evaluation, the true cause might have been overlooked, leaving the patient vulnerable to years of unnecessary treatment and an increased risk of complications.

These stories—from Mumbai to Milan to Tehran—share a common lesson: when it comes to complex, treatment-resistant conditions, precision diagnostics can mean the difference between years of trial-and-error therapy and a targeted, effective solution. They demonstrate that the future of healthcare delivery is not just about more technology or more treatment—it is about smarter, evidence-driven decisions that put the patient’s unique biology at the centre of care.